Iovance Biotherapeutics, Inc. (LON:0JDK)
5.77
+0.19 (3.45%)
At close: Feb 21, 2025
Iovance Biotherapeutics Employees
Iovance Biotherapeutics had 557 employees as of December 31, 2023. The number of employees increased by 54 or 10.74% compared to the previous year.
Employees
557
Change (1Y)
54
Growth (1Y)
10.74%
Revenue / Employee
121.70K GBP
Profits / Employee
-549.19K GBP
Market Cap
1.39B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
Hikma Pharmaceuticals | 9,100 |
ConvaTec Group | 10,136 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
Iovance Biotherapeutics News
- 6 hours ago - Iovance Biotherapeutics Inc (IOVA) Announces Inducement Stock Options for New Employees - GuruFocus
- 4 days ago - Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025 - GlobeNewsWire
- 8 days ago - PERCEPTIVE ADVISORS LLC Reduces Stake in Iovance Biotherapeutics Inc - GuruFocus
- 10 days ago - Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 12 days ago - Iovance Biotherapeutics Shares Fell Today: What's Going On? - Benzinga
- 13 days ago - Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer - GlobeNewsWire
- 24 days ago - What's Wrong With Iovance Biotherapeutics Stock? - The Motley Fool
- 25 days ago - Where Will Iovance Biotherapeutics Be in 5 Years? - The Motley Fool